Skip to main content
VCbacked
Log inGet Started

Pathios Therapeutics

Oxford, United Kingdom

Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.

$25.0M raised
Apr 2024
Series B
BiotechnologyHealth CareTherapeutics

Top Investors

Brandon CapitalBristol-Myers SquibbInnovate UKCanaan PartnersMedical Research Commercialisation Fund (MRCF)

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Pathios Therapeutics

How much funding has Pathios Therapeutics raised?
Pathios Therapeutics has raised $25.0M in total funding. The most recent round was Series B. The last funding was announced in April 2024.
Who are Pathios Therapeutics's investors?
Pathios Therapeutics's investors include Brandon Capital, Bristol-Myers Squibb, Innovate UK, Canaan Partners, Medical Research Commercialisation Fund (MRCF).
Where is Pathios Therapeutics headquartered?
Pathios Therapeutics is headquartered in Oxford, United Kingdom.
What does Pathios Therapeutics do?
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.
What stage is Pathios Therapeutics at?
Pathios Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Pathios Therapeutics — Funding & Investors." VCBacked, April 18, 2024, https://www.vcbacked.co/company/pathios-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Pathios Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/pathios-therapeutics
Wikipedia (cite web)
{{cite web |title=Pathios Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pathios-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong